Syros Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Nov 29, 2023, 5:29 p.m.





-0.13 -4.73%


Volume 45

Quotes are delayed by 20 min


Today's close

$ 2.59

$ 2.75


+0.16 +6.18%

Day low

Day high




52 week low

52 week high




Annual Financials for Syros Pharmaceuticals Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Net Income before Extraordinaries (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
Depreciation, Depletion & Amortization 1.6M2.72M3.04M3.02M2.97M
Depreciation and Depletion 1.6M2.72M3.04M3.02M2.97M
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 5.97M8.71M11.55M(5.4M)(25.86M)
Funds from Operations (54.71M)(64.01M)(69.45M)(88.94M)(117.55M)
Extraordinaries -----
Changes in Working Capital 14.39M3.75M12.09M(10.6M)(5.52M)
Receivables -(20.16M)17.83M(648,000)1.29M
Accounts Payable 888,0001.49M(1.06M)48,0002.77M
Other Assets/Liabilities 9.31M26M(5.28M)(14.83M)(11.91M)
Net Operating Cash Flow (40.32M)(60.25M)(57.36M)(99.54M)(123.07M)

Investing Activities

20182019202020212022 5-year trend
Capital Expenditures (1.38M)(12.64M)(3.34M)(1.25M)(1.24M)
Capital Expenditures (Fixed Assets) (1.38M)(12.64M)(3.34M)(1.25M)(1.24M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses 9,000110,000---
Purchase/Sale of Investments (9.27M)794,00050M(51.41M)68.43M
Purchase of Investments (96.77M)(108.21M)-(51.41M)-
Sale/Maturity of Investments 87.5M109M50M-68.43M
Other Uses -----
Other Sources -----
Net Investing Cash Flow (10.64M)(11.73M)46.66M(52.65M)67.19M

Financing Activities

20182019202020212022 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 69.13M66.2M103.78M70.78M119.87M
Repurchase of Common & Preferred Stk. ----(81,000)
Sale of Common & Preferred Stock 69.13M66.2M103.78M70.78M119.96M
Proceeds from Stock Options 69.13M66.2M103.78M70.78M119.96M
Other Proceeds from Sale of Stock -----
Issuance/Reduction of Debt, Net (50,000)(205,000)39.17M(265,000)(591,000)
Change in Current Debt -----
Change in Long-Term Debt (50,000)(205,000)39.17M(265,000)(591,000)
Issuance of Long-Term Debt --39.41M--
Reduction in Long-Term Debt (50,000)(205,000)(241,000)(265,000)(591,000)
Other Funds ----11.76M
Other Uses -----
Other Sources ----11.76M
Net Financing Cash Flow 69.08M65.99M142.95M70.51M131.05M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash 18.13M(6M)132.25M(81.68M)75.17M
Free Cash Flow (41.7M)(72.89M)(60.7M)(100.79M)(124.31M)
Link to MarketWatch's Slice.